GLIMIHEAL M2 combines Glimepiride 2 mg and Metformin 500 mg, and is used for managing type 2 diabetes when diet and exercise aren’t enough to control blood glucose levels .
Glimepiride boosts insulin release from the pancreas, while Metformin reduces liver glucose production and improves insulin sensitivity, resulting in better steady‑state glucose control .
Typical side effects include hypoglycemia, nausea, diarrhea, stomach pain, metallic taste, headache, and weight gain; rare but serious risks include lactic acidosis and vitamin B₁₂ deficiency with long‑term use—use under medical supervision with regular monitoring
